Cargando...
Upregulation of ERCC6L is associated with tumor progression and unfavorable prognosis in hepatocellular carcinoma
BACKGROUND: The oncogenic role of excision repair cross-complementation group 6-like (ERCC6L) has been revealed in several cancers recently, but little is known about its expression and function in hepatocellular carcinoma (HCC). METHODS: Utilizing public data from Human Protein Atlas (HPA) and The...
Guardado en:
| Publicado en: | J Gastrointest Oncol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7657825/ https://ncbi.nlm.nih.gov/pubmed/33209494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-192 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|